It continues to be frustrating for you. It's the same here.
Sovaldi has been approved for use in Australia, but the Government refuses to fund it. So, you can get it, if you're rich.
For some strange reason, the Government has agreed to fund Olysio. However Olysio/Peg/Riba is no better than the early antiproteases, so Hepatologists are not prescribing it.
We're waiting for AbbVie. Cheers.
Cinnamon Girl said
Sep 28, 2014
Hello Rebeca, good to hear from you.
Unfortunately this is a very common situation with other European countries too.
This is the only recent article I could find, which just says that the drug will be made on available on prescription from the National Health Service in Spain this week, on wed 1st October, after the health ministry reached an agreement over the price, but no details about the recommended treatment restrictions..
Do you have a link to any further information, please Rebecca, or can you post when you hear more?
And yes, you`re quite right about the situation in Australia. It`s very disappointing but comes down to the cost, unfortunately.
You have time to wait, so try not to be too downhearted!
rebeca said
Sep 27, 2014
Spain´s health ministry has reach an agreement with the drug company to be able to offer Sovaldi to some patients.
The new is really good, but don´t think that we can all get it. It will be offer to patients in one of those conditions:
- They have a liver transplant and they are reinfected
- They are on the list to receive a transplant
-They have a severe cirrosis (treatment failure)( they will make a commission to assess whether cirrosis is very serious).
Patient associations estimate that there are between 8000 and 5000 persons in that situation in Spain, but we don´t know more at the moment.
On the other hand, Simeprevir is posible to offer in Spain since July, but in practise, they are not prescribed to anyone. We think that you can get it if you have a F4, but we don´t know.
People with mild disease (F2-F3),and genotype 1, at the moment, we can only access the dual therapy ( INT+RIBA).
AND WHAT´S ABOUT AUSTRALIA? I´ve read that Government refuses subsidy for hepatitis C medication, Sovaldi.
Hi Rebeca,
It continues to be frustrating for you. It's the same here.
Sovaldi has been approved for use in Australia, but the Government refuses to fund it. So, you can get it, if you're rich.
For some strange reason, the Government has agreed to fund Olysio. However Olysio/Peg/Riba is no better than the early antiproteases, so Hepatologists are not prescribing it.
We're waiting for AbbVie. Cheers.
Hello Rebeca, good to hear from you.
Unfortunately this is a very common situation with other European countries too.
This is the only recent article I could find, which just says that the drug will be made on available on prescription from the National Health Service in Spain this week, on wed 1st October, after the health ministry reached an agreement over the price, but no details about the recommended treatment restrictions..
http://hcvadvocate.blogspot.ca/2014/09/spain-expensive-hepatitis-c-drug-with.html
Do you have a link to any further information, please Rebecca, or can you post when you hear more?
And yes, you`re quite right about the situation in Australia. It`s very disappointing but comes down to the cost, unfortunately.
You have time to wait, so try not to be too downhearted!
Spain´s health ministry has reach an agreement with the drug company to be able to offer Sovaldi to some patients.
The new is really good, but don´t think that we can all get it. It will be offer to patients in one of those conditions:
- They have a liver transplant and they are reinfected
- They are on the list to receive a transplant
-They have a severe cirrosis (treatment failure)( they will make a commission to assess whether cirrosis is very serious).
Patient associations estimate that there are between 8000 and 5000 persons in that situation in Spain, but we don´t know more at the moment.
On the other hand, Simeprevir is posible to offer in Spain since July, but in practise, they are not prescribed to anyone. We think that you can get it if you have a F4, but we don´t know.
People with mild disease (F2-F3),and genotype 1, at the moment, we can only access the dual therapy ( INT+RIBA).
AND WHAT´S ABOUT AUSTRALIA? I´ve read that Government refuses subsidy for hepatitis C medication, Sovaldi.